Stefaplex

ACTIVE INGREDIENT

Letrozole

INDICATIONS

  • Adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer.

  • Extended adjuvant treatment of early breast cancer in postmenopausal women who have received 5 years of adjuvant tamoxifen therapy

  • first-line treatment of postmenopausal women with hormone receptor positive or hormone receptor unknown locally advanced or metastatic breast cancer

  • treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy.

FORMS

f.c. tab 2,5 mg x 30

T.: 210 9423677   info@opusmateria.gr

THE COMPANY

© 2019 BY FM STUDIO

CONTACT INFORMATION

33 Konstantinou Palaiologou street, Palaio Faliro, Attica, Greece.

175 64

+30 210 9423 677

info@opusmateria.gr